Citigroup’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.26M Buy
+26,000
New +$8.36M ﹤0.01% 1685
2025
Q1
– Sell
-49,000
Closed -$6.49M – 6034
2024
Q4
$6.49M Sell
49,000
-107,800
-69% -$10.1M ﹤0.01% 1712
2024
Q3
$8.21M Buy
+156,800
New +$7.36M ﹤0.01% 1454

Other funds holding ALAB

Citigroup's ALAB Position: Q3 2026 in Review

Citigroup reduced its Astera Labs (ALAB) stake by 58% in Q3 2026, selling an estimated $254M and leaving 564,068 shares worth $201M. The position accounts for 0.07% of the portfolio, ranked #274.

Citigroup first reported a position in ALAB in Q2 2024 and has held it in 10 quarters since. The position peaked at $653M in Q2 2026. 394 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Citigroup held 564,068 shares of Astera Labs worth $201M as of Q3 2026.
  • Citigroup sold 788,068 Astera Labs shares in Q3 2026, an estimated $254M.
  • Astera Labs made up 0.07% of Citigroup's portfolio in Q3 2026, its #274 holding.
  • Citigroup first reported a position in Astera Labs in Q2 2024 and has held it in 10 quarters since.
  • Citigroup's Astera Labs position peaked at $653M in Q2 2026.
  • 394 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.